Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

A new method using fat tissue cells may help treat hair loss.

Artemis dysfunction might cause hair loss through telomere shortening.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Minoxidil helps hair regrowth in traction alopecia.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Combining intradermotherapy with microneedling and a topical solution reduces hair loss more effectively than intradermotherapy alone.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Androgenic alopecia causes hair thinning, and treatments include minoxidil, finasteride, and light therapy.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

A woman had temporary hair loss due to a stress-related condition after a facelift.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

AGA affects many, progresses differently, and early treatment is crucial.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Scientists created a model using sheep cells to study hair root formation, which can test how different substances affect hair growth.